Reiter's disease, unspecified hip
ICD-10 M02.359 is a billable code used to indicate a diagnosis of reiter's disease, unspecified hip.
Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that typically develops in response to an infection in another part of the body. It is characterized by the classic triad of arthritis, urethritis, and conjunctivitis. In the case of unspecified hip involvement, the hip joint may exhibit swelling, pain, and reduced range of motion due to inflammation. Anatomically, the hip joint is a ball-and-socket joint formed by the acetabulum of the pelvis and the head of the femur, allowing for a wide range of motion. Pathophysiologically, Reiter's disease is associated with an autoimmune response triggered by infections, often involving the urogenital or gastrointestinal tract. Clinically, patients may present with unilateral or bilateral hip pain, stiffness, and difficulty with weight-bearing activities. The condition can lead to chronic joint damage if not managed appropriately, necessitating a comprehensive treatment approach that includes anti-inflammatory medications, physical therapy, and lifestyle modifications.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage, functional assessments to evaluate mobility, and detailed notes on the patient's range of motion.
Common scenarios include patients presenting with acute hip pain following a recent infection, requiring surgical intervention for joint debridement or arthroscopy.
Joint-specific considerations include the degree of inflammation, presence of effusion, and impact on weight-bearing activities.
Rheumatologic documentation should include laboratory tests for inflammatory markers (ESR, CRP), HLA-B27 antigen testing, and assessments of disease activity using validated scales.
Patients may present with systemic symptoms such as fever and malaise alongside joint pain, necessitating a comprehensive evaluation for autoimmune conditions.
Consideration of systemic involvement, such as ocular or genitourinary symptoms, is crucial for accurate diagnosis and treatment planning.
Functional assessments should document the patient's ability to perform activities of daily living and any assistive devices used for mobility.
Rehabilitation scenarios may include post-acute care for patients recovering from severe flare-ups, focusing on restoring mobility and strength.
Mobility limitations should be clearly documented, including the need for physical therapy interventions and assistive devices.
Used for patients with significant joint effusion in the hip requiring drainage or corticosteroid injection.
Documentation must include the indication for the procedure, joint involved, and any imaging guidance used.
Orthopedic considerations include the need for imaging to assess joint effusion prior to the procedure.
Common symptoms include joint pain and swelling, particularly in the knees, ankles, and hips, along with possible systemic symptoms such as conjunctivitis and urethritis. Patients may also experience stiffness and reduced range of motion in affected joints.
